Importance Multisystem inflammatory syndrome in children (MIS-C) is associated with recent
or current SARS-CoV-2 infection. Information on MIS-C incidence is limited. Objective To …

Background Spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
B.1.1.529 (omicron) variant, which led to increased US hospitalizations for coronavirus …

Background Infants younger than 6 months of age are at high risk for complications of
coronavirus disease 2019 (Covid-19) and are not eligible for vaccination. Transplacental transfer …

Background The increasing incidence of pediatric hospitalizations associated with
coronavirus disease 2019 (Covid-19) caused by the B.1.617.2 (delta) variant of severe acute …

Importance Multiple inflammatory syndrome in children (MIS-C) occurs in association with
the COVID-19 pandemic. Objective To describe the clinical characteristics and geographic …

OBJECTIVES Describe population-based rates and risk factors for pediatric severe coronavirus
disease 2019 (COVID-19) (ie, ICU admission, invasive mechanical ventilation, or death). …

Background Multisystem inflammatory syndrome in children (MIS-C) is a newly identified
and serious health condition associated with SARS-CoV-2 infection. Clinical manifestations …

Importance Multisystem inflammatory syndrome in adults (MIS-A) has not been well
described. Improved diagnosis and treatment of MIS-A might mitigate COVID-19 morbidity and …

Background Multisystem inflammatory syndrome in children (MIS-C) is a hyperinflammatory
condition associated with antecedent SARS-CoV-2 infection. In the USA, reporting of MIS-C …

BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of hospitalized acute
respiratory illness (ARI) among young children. With RSV vaccines and immunoprophylaxis …